Oppenheimer & Co. Inc. acquired a new position in shares of ARK Genomic Revolution ETF (BATS:ARKG – Free Report) in the third quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 30,016 shares of the company’s stock, valued at approximately $1,627,000. Oppenheimer & Co. Inc. owned about 0.07% of […]

Oppenheimer & Co. Inc. purchased a new position in Amplify Cybersecurity ETF (NYSEARCA:HACK – Free Report) during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 76,410 shares of the company’s stock, valued at approximately $9,264,000. Oppenheimer & Co. Inc. owned […]